Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05564091 · ClinicalTrials.gov registry record · NA
Cataract Surgery in Conjunction With Ab-interno Canaloplasty Compared to Cataract Surgery Only in Patients With Mild to Moderate Primary Open-Angle Glaucoma
A NA study of Primary Open Angle Glaucoma, sponsored by Nova Eye.
- Recruiting
- Registry status
- NA
- Development phase
- 78
- Enrollment target
- 4
- Study locations
NCT05564091: Recruiting NA study of Primary Open Angle Glaucoma, sponsored by Nova Eye.
NCT05564091 is a NA study of Primary Open Angle Glaucoma that is actively recruiting participants, run by Nova Eye. The registered enrollment target is 78 participants, below the 290-participant average among 19 other Primary Open Angle Glaucoma trials with a reported enrollment target (73% lower). The trial reports 4 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05564091, a NA study of Primary Open Angle Glaucoma, is actively recruiting participants, sponsored by Nova Eye.
- RECRUITING
- Registry status
- NA
- Development phase
- 78 participants
- Enrollment target
- 4
- Study locations
Study Summary
A prospective, multicenter, randomized, single-masked, post-market clinical trial comparing cataract surgery in conjunction with ab-interno canaloplasty utilizing the iTrack Advance canaloplasty device (Nova Eye, Inc.) to cataract surgery only in patients with mild to moderate, primary open angle glaucoma. Subjects will be followed for 24 months.
Primary Outcome
IOP will be measured at each study visit using Goldmann applanation tonometry
Conditions Studied
Interventions
- PROCEDURE Cataract surgery
- DEVICE Cataract surgery combined with ab-interno canaloplasty utililzing the iTrack Advance canaloplasty device
Study Locations (4)
Other
- University of Bonn Eye Clinic - Bonn
- Augencentrum Köln Ophthalmology - Cologne
- St. Johannes Hospital - Dortmund
Texas
- Berkeley Eye Center - Sugar Land
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2022-09-08 |
| Est. Completion | 2027-07 |
| Phase | NA |
What NCT05564091 shows while recruiting
NCT05564091 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 78 participants, a relatively small participant target, below the 290-participant average among 19 other Primary Open Angle Glaucoma trials with a reported enrollment target (73% lower).
The record links to 1 condition, with Primary Open Angle Glaucoma appearing as the primary indexed condition, and to 2 interventions - of which Cataract surgery is the first listed.
NCT05564091 reports a single indexed study location in Other, Texas.
Frequently Asked Questions
What is clinical trial NCT05564091 about?
NCT05564091 is a clinical study titled "Cataract Surgery in Conjunction With Ab-interno Canaloplasty Compared to Cataract Surgery Only in Patients With Mild to Moderate Primary Open-Angle Glaucoma". A prospective, multicenter, randomized, single-masked, post-market clinical trial comparing cataract surgery in conjunction with ab-interno canaloplasty utilizing the iTrack Advance canaloplasty device (Nova Eye, Inc.) to cataract surgery only in patients with mild to moderate, primary open angle gl...
What is the current status of trial NCT05564091?
This trial is currently recruiting. It is a NA study. The enrollment target is 78 participants. The study started on 2022-09-08. Estimated completion is 2027-07.
What conditions does trial NCT05564091 study?
This clinical trial studies the following conditions: Primary Open Angle Glaucoma.
What interventions are being tested in trial NCT05564091?
The interventions under investigation include: Cataract surgery (PROCEDURE), Cataract surgery combined with ab-interno canaloplasty utililzing the iTrack Advance canaloplasty device (DEVICE).
Who is sponsoring clinical trial NCT05564091?
This trial is sponsored by Nova Eye, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05564091 being conducted?
This trial has 4 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Primary Open Angle Glaucoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05564091's enrollment target sits among peer trials
78 15th of 19 higher than 5 of 19 other Primary Open Angle Glaucoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Primary Open Angle Glaucoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Hydrus® Microstent New Enrollment Post-Approval Study
RECRUITING · NA
-
Safety and Effectiveness of Minimally Invasive Micro Sclerostomy (MIMS®) to Reduce Intraocular Pressure in Open-Angle Glaucoma Which is Not Controlled Despite Polypharmacy
RECRUITING · NA
-
Nanodropper Use in Primary Open-Angle Glaucoma Patients: A Non-Inferiority Trial
RECRUITING · NA
-
Comparing Effectiveness of the Hydrus Microstent (TM) to Two iStents to Lower IOP in Phakic Eyes
COMPLETED · NA
-
The Effects of Visior on Ocular Hemodynamics
COMPLETED · NA
-
A Study of AMDX-2011P in Participants With Primary Open Angle Glaucoma
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02397668 · 78 participants · NA
CorMatrix Cor TRICUSPID ECM Valve Replacement Study
- NCT03321656 · 78 participants · Phase 2
Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile
- NCT03687814 · 78 participants · NA
Low FODMAP Plus PEG 3350 for the Treatment of Patients with Irritable Bowel Syndrome-Constipation
- NCT04018872 · 78 participants · Phase 2
Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI